Eric P F Chow Selected Research

Condoms (Condom)

1/2023	Sexual activities and condom use among heterosexual men and women engaged in mixed-gender group sex events in Melbourne, Australia.
1/2023	High-Risk Sexual Activities and Condom Use Patterns During Group Sex Among Men Who Have Sex With Men in Melbourne, Australia.
1/2022	Web-Based Risk Prediction Tool for an Individual's Risk of HIV and Sexually Transmitted Infections Using Machine Learning Algorithms: Development and External Validation Study.
1/2022	Sexual Activities and Changes in Condom Use in Group Sex Events Among Female Sex Workers in Melbourne, Australia.
1/2022	Non-conventional interventions to prevent gonorrhea or syphilis among men who have sex with men: A scoping review.
1/2021	Predicting the diagnosis of HIV and sexually transmitted infections among men who have sex with men using machine learning approaches.
11/2020	Getting to the Bottom of It: Sexual Positioning and Stage of Syphilis at Diagnosis, and Implications for Syphilis Screening.
5/2020	The safe use of dating applications among men who have sex with men: a study protocol for a randomised controlled trial to evaluate an interactive web-based intervention to reduce risky sexual behaviours.
11/2018	Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP Trial.
1/2018	Rising Chlamydia and Gonorrhoea Incidence and Associated Risk Factors Among Female Sex Workers in Australia: A Retrospective Cohort Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric P F Chow Research Topics

Disease

22	Infections 04/2024 - 12/2012
18	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2024 - 11/2018
11	Gonorrhea 04/2024 - 02/2015
10	Syphilis 09/2023 - 01/2021
5	Urethritis 10/2022 - 02/2017
4	Condylomata Acuminata (Genital Wart) 12/2021 - 05/2015
4	HIV Infections (HIV Infection) 10/2019 - 04/2012
3	Proctitis 03/2024 - 01/2018
3	Bacterial Vaginosis 01/2023 - 10/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2023 - 10/2020
2	COVID-19 01/2023 - 12/2021
2	Coinfection 01/2023 - 06/2012
2	Weight Gain 01/2023 - 11/2022
2	Vomiting 01/2022 - 01/2021
2	Nausea 01/2022 - 01/2021
2	Reinfection 01/2022 - 01/2019
2	primary Syphilis 01/2022 - 11/2020
2	Chlamydia Infections 01/2021 - 01/2018
2	Hepatitis A (Hepatitis, Infectious) 01/2020 - 01/2020
2	Lymphogranuloma Venereum 01/2017 - 10/2016
1	Meningitis 04/2024
1	Mpox (monkeypox) 10/2023
1	Dysbiosis 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Yaws 12/2022
1	Vulvovaginal Candidiasis 01/2022
1	Papillomavirus Infections 09/2021
1	Pruritus (Itching) 09/2021
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2021
1	Candidiasis (Moniliasis) 01/2021
1	Diarrhea 01/2021
1	secondary Syphilis 01/2021
1	Suppuration 01/2020
1	Vaginal Discharge 01/2020
1	Uterine Cervicitis (Cervicitis) 01/2019
1	Warts (Wart) 01/2018
1	Disease Progression 06/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2015

Drug/Important Bio-Agent (IBA)

10	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 10/2016
8	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 01/2017
7	MacrolidesIBA 08/2023 - 02/2017
7	Doxycycline (Periostat)FDA LinkGeneric 01/2022 - 10/2016
6	Moxifloxacin (Avelox)FDA Link 12/2023 - 01/2018
5	VaccinesIBA 04/2024 - 01/2019
4	Nucleic AcidsIBA 04/2024 - 01/2017
3	sitafloxacinIBA 12/2023 - 01/2019
3	AntibodiesIBA 09/2023 - 01/2022
3	ReaginsIBA 01/2023 - 01/2021
3	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2018
3	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022 - 01/2019
3	PristinamycinIBA 01/2020 - 01/2018
3	LubricantsIBA 01/2019 - 10/2016
2	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 01/2019
2	IntegrasesIBA 01/2023 - 11/2022
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 01/2021
2	Combined VaccinesIBA 10/2021 - 01/2019
2	ORALIT (ORS)IBA 01/2018 - 05/2015
2	Bacterial DNAIBA 11/2017 - 10/2016
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2012 - 06/2012
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 04/2024
1	4CMenB vaccineIBA 04/2024
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 10/2023
1	Minocycline (Cyclops)FDA LinkGeneric 08/2023
1	FluoroquinolonesIBA 08/2023
1	Messenger RNA (mRNA)IBA 05/2023
1	ApolipoproteinsIBA 01/2023
1	MouthwashesIBA 01/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2022
1	3- (2- pyridyl)- 5,6- diphenyl- 1,2,4- triazineIBA 01/2022
1	16S Ribosomal RNAIBA 10/2021
1	Imiquimod (Aldara)FDA LinkGeneric 09/2021
1	ElementsIBA 10/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Green OrIBA 01/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2018
1	mesoglycanIBA 01/2016
1	antibiotic K 4 (K 4)IBA 12/2012
1	Methadone (Dolophine)FDA LinkGeneric 12/2012

Therapy/Procedure

13	Condoms (Condom) 01/2023 - 04/2012
6	Therapeutics 11/2022 - 01/2019
3	Ambulatory Care (Outpatient Care) 09/2023 - 10/2019
3	Self-Testing 01/2023 - 01/2022
2	Aftercare (After-Treatment) 01/2022 - 01/2018
1	Contraindications 08/2023
1	Art Therapy 12/2021
1	Highly Active Antiretroviral Therapy (HAART) 06/2015